Followers | 128 |
Posts | 2150 |
Boards Moderated | 1 |
Alias Born | 12/27/2007 |
Tuesday, April 05, 2016 7:39:53 AM
http://www.iramarketreport.com/steadymeds-stdy-buy-rating-reiterated-at-jmp-securities/49753/
JMP Securities reiterated their buy rating on shares of Steadymed Ltd (NASDAQ:STDY) in a report issued on Wednesday morning, AnalystRatingsNetwork.com reports. JMP Securities currently has a $9.00 price target on the stock.
An institutional investor recently raised its position in Steadymed stock. Jennison Associates raised its position in Steadymed Ltd (NASDAQ:STDY) by 0.3% during the third quarter, Holdings Channel reports. The firm owned 432,255 shares of the company’s stock after buying an additional 1,159 shares during the period. Jennison Associates owned about 3.18% of Steadymed worth $1,535,000 at the end of the most recent reporting period.
Separately, RBC Capital reaffirmed a buy rating on shares of Steadymed in a research note on Monday, March 28th.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM